News
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...
Researchers at the Francis Crick Institute and UCL have shown that genetic messages are misplaced in nerve cells in a model ...
Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.
The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...
5d
News-Medical.Net on MSNClinical trial examines whether Ambroxol can slow dementia in people with Parkinson'sResearchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...
Help Black families facing dementia. Join SHARE, a clinical trial for support, health, activities, resources, and education.
11d
Study Finds on MSNTaking Semaglutide Could Cut Dementia Risk Nearly In Half, Case Western Study ShowsBeyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...
The team used a special type of brain scan called tau PET, which tracks a protein known as tau that builds up in the brain ...
Diabetes drug semaglutide linked to reduced risk of dementia in type 2 diabetes patients Effects strongest in women and older ...
A massive U.S. study found diabetics on semaglutide (Ozempic’s active ingredient) had up to 70% lower risk of ...
The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results